This is filed to report tissue damage and recurrent mitral regurgitation it was reported on (b)(6) 2023, a mitraclip procedure was performed to treat functional mitral regurgitation (mr) with a grade of 4+ and an enlarged atrium.One xtw clip was implanted, reducing mr to a grade of 1.On (b)(6) 2023, the patient returned to the hospital with symptoms of dyspnea and fatigue.Echocardiography showed a potential tissue injury to the anterior leaflet, causing mr to return to a grade of 4+.On (b)(6) 2023, an additional mitraclip procedure was performed.To treat mr, an additional xt clip was deployed laterally and successfully implanted.To further reduce mr, a second nt clip was inserted.However, before deployment, it was noted mr returned, blood pressure increased, and a tissue injury to the anterior leaflet was observed.Therefore, the clip was removed, and the procedure was discontinued.Mr remained at a grade of 4+.No additional information was provided.
|
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to the reported event.Based on the information reviewed, a cause for the unspecified tissue injury to the anterior leaflet resulting in mitral valve insufficiency/regurgitation (recurrent) cannot be determined.The reported dyspnea and fatigue however, were cascading effects of the recurrent mr.Mitral regurgitation, dyspnea and tissue damage are listed in the instructions for use (ifu) as known possible complications associated with mitraclip procedures.Unexpected medical intervention and hospitalization were a result of case-specific circumstances.There is no indication of a product issue with respect to manufacture, design or labeling.The additional mitraclip device referenced in b5 is being filed under a separate medwatch report.
|